Conard J, Morisot P, Huguet C
Nouv Presse Med. 1976 Nov 13;5(38):2519-23.
Changes in blood coagulation have been studied during and after 20 elective hepatic lobectomies, most of them for tumors necessitating extensive resection (17 right lobectomies, 10 of which were extended to the medial segment of the left lobe). In addition, 9 unresectable tumors, as proved by exploratory laparotomy, were taken for controls. Before operation, hemostasis in essentially normal except a hyperfibrinogenemia and a slight increase of fibrinogen split products in half the cases. Factor VIII antigen levels are consistently increased. During mobilization of the liver an increased fibrinolytic activity and soluble complexes are frequently observed. Fibrinolysic activity spontaneously returns to normal at the end of the operation, except in cirrhotic patients. No bleeding disthesis is observed and haemorrhage appears to be related to technical problems. On the other hand, there is no clinical evidence of thromboembolism after operation. Therefore any specific therapy either pro or anti-coagulant, appears unjustified, apart from the eventual and transient administration of antifibrinolytic drugs in cirrhotic patients. In the post operative period, blood clotting factors synthetized by the liver (prothrombin complex and antithrombin III) slowly return to normal. Rapid correction of hypo-accelerinaemia reflects the onset of liver regeneration. A simplified method for surveying hemostasis during and after liver resection is proposed.
对20例择期肝叶切除术患者术中及术后的凝血变化进行了研究,其中大多数患者因肿瘤需要进行广泛切除(17例右叶切除术,其中10例扩展至左叶内侧段)。此外,选取9例经剖腹探查证实无法切除的肿瘤患者作为对照。术前,除半数病例存在高纤维蛋白原血症和纤维蛋白原降解产物略有增加外,止血功能基本正常。因子VIII抗原水平持续升高。在肝脏游离过程中,常观察到纤溶活性增加和可溶性复合物。除肝硬化患者外,纤溶活性在手术结束时自发恢复正常。未观察到出血素质,出血似乎与技术问题有关。另一方面,术后没有血栓栓塞的临床证据。因此,除了在肝硬化患者中最终短暂使用抗纤溶药物外,任何促凝或抗凝的特异性治疗似乎都不合理。在术后,肝脏合成的凝血因子(凝血酶原复合物和抗凝血酶III)缓慢恢复正常。低加速素血症的快速纠正反映了肝脏再生的开始。提出了一种简化的方法来监测肝切除术中及术后的止血情况。